These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25016058)

  • 1. A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissues.
    Brehm H; Niesen J; Mladenov R; Stein C; Pardo A; Fey G; Helfrich W; Fischer R; Gattenlöhner S; Barth S
    Cancer Lett; 2014 Oct; 352(2):228-35. PubMed ID: 25016058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
    Schwenkert M; Birkholz K; Schwemmlein M; Kellner C; Kügler M; Peipp M; Nettelbeck DM; Schuler-Thurner B; Schaft N; Dörrie J; Ferrone S; Kämpgen E; Fey GH
    Melanoma Res; 2008 Apr; 18(2):73-84. PubMed ID: 18337643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.
    Gattenlöhner S; Jörissen H; Huhn M; Vincent A; Beeson D; Tzartos S; Mamalaki A; Etschmann B; Muller-Hermelink HK; Koscielniak E; Barth S; Marx A
    J Biomed Biotechnol; 2010; 2010():187621. PubMed ID: 20204062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells.
    Staudinger M; Glorius P; Burger R; Kellner C; Klausz K; Günther A; Repp R; Klapper W; Gramatzki M; Peipp M
    Blood Cancer J; 2014 Jun; 4(6):e219. PubMed ID: 24927408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody internalization studied using a novel IgG binding toxin fusion.
    Mazor Y; Barnea I; Keydar I; Benhar I
    J Immunol Methods; 2007 Apr; 321(1-2):41-59. PubMed ID: 17336321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z; Feng Z; Zhu X; Xu W; Zhu J; Zhang X; Fan Z; Ji G
    Immunol Lett; 2013 Jan; 149(1-2):30-40. PubMed ID: 23026237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells.
    Tur MK; Huhn M; Thepen T; Stöcker M; Krohn R; Vogel S; Jost E; Osieka R; van de Winkel JG; Fischer R; Finnern R; Barth S
    Cancer Res; 2003 Dec; 63(23):8414-9. PubMed ID: 14679004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.
    Niesen J; Brehm H; Stein C; Berges N; Pardo A; Fischer R; Ten Haaf A; Gattenlöhner S; Tur MK; Barth S
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1049-61. PubMed ID: 25433506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The melanoma specific 9.2.27PE immunotoxin efficiently kills melanoma cells in vitro.
    Risberg K; Fodstad Ø; Andersson Y
    Int J Cancer; 2009 Jul; 125(1):23-33. PubMed ID: 19350633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.
    Niesen J; Stein C; Brehm H; Hehmann-Titt G; Fendel R; Melmer G; Fischer R; Barth S
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2079-95. PubMed ID: 25899161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia.
    Fitting J; Blume T; Ten Haaf A; Blau W; Gattenlöhner S; Tur MK; Barth S
    MAbs; 2015; 7(2):390-402. PubMed ID: 25760770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A.
    Akbari B; Farajnia S; Zarghami N; Mahdieh N; Rahmati M; Khosroshahi SA; Barzegar A; Rahbarnia L
    Anticancer Drugs; 2017 Mar; 28(3):263-270. PubMed ID: 27861173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunoconjugate of anti-CD24 and Pseudomonas exotoxin selectively kills human colorectal tumors in mice.
    Shapira S; Shapira A; Starr A; Kazanov D; Kraus S; Benhar I; Arber N
    Gastroenterology; 2011 Mar; 140(3):935-46. PubMed ID: 21147107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
    Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
    Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing the furin-cleavable linker in recombinant immunotoxins based on Pseudomonas exotoxin A.
    Weldon JE; Skarzynski M; Therres JA; Ostovitz JR; Zhou H; Kreitman RJ; Pastan I
    Bioconjug Chem; 2015 Jun; 26(6):1120-8. PubMed ID: 25997032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
    Zielinski R; Lyakhov I; Jacobs A; Chertov O; Kramer-Marek G; Francella N; Stephen A; Fisher R; Blumenthal R; Capala J
    J Immunother; 2009 Oct; 32(8):817-25. PubMed ID: 19752752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].
    Grieger E; Gresch G; Niesen J; Woitok M; Barth S; Fischer R; Fendel R; Stein C
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2159-2170. PubMed ID: 28669053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
    Schwemmlein M; Peipp M; Barbin K; Saul D; Stockmeyer B; Repp R; Birkmann J; Oduncu F; Emmerich B; Fey GH
    Br J Haematol; 2006 Apr; 133(2):141-51. PubMed ID: 16611304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.
    Peipp M; Küpers H; Saul D; Schlierf B; Greil J; Zunino SJ; Gramatzki M; Fey GH
    Cancer Res; 2002 May; 62(10):2848-55. PubMed ID: 12019163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemical conjugate between HER2-targeting antibody fragment and Pseudomonas exotoxin A fragment demonstrates cytotoxic effects on HER2-expressing breast cancer cells.
    Lee S; Park S; Nguyen MT; Lee E; Kim J; Baek S; Kim CJ; Jang YJ; Choe H
    BMB Rep; 2019 Aug; 52(8):496-501. PubMed ID: 30670149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.